Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Alex Shaver

Alex Shaver

ID: 1b8393cd-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline – Updated January 22, 2026

Biosimilars Law Bulletin · January 22, 2026

District Circuit Denies Novartis’s Request for Injunctive Relief Against MSN’s Generic Version of Entresto®

Biosimilars Law Bulletin · July 18, 2025

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline – Updated May 2, 2025

Biosimilars Law Bulletin · May 5, 2025

How the U.S. Compares to Europe on Biosimilar Approvals and Products In the Pipeline – Updated January 13, 2025

Biosimilars Law Bulletin · January 14, 2025

USPTO Finalizes Fee Increases for 2025: What to Expect in the New Year and What to do Now

RF EMerge · November 20, 2024

Previous

12

Next

Practice Areas

Health Care and Life Sciences

Business and Commercial

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2023

Total Articles 7

Most Recent January 22, 2026

Cite This Author

Alex Shaver, Rothwell Figg

LexBlog Author ID:

1b8393cd-2619-30fb-68c4

www.lexblog.com/author/ashaverrothwellfigg-com

Contact

FirmRothwell Figg

Emailashaver@rothwellfigg.com

BlogsBiosimilars Law Bulletin

LinkedInView Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog